The behaviour of cyclic-3',5'-AMP phosphodiesterase has been studied in the presence of psoralen, 8-methoxypsoralen (8-MOP), 4,5',8-trimethylpsoralen (TMP) (usu ally used in PUVA therapy), 4.6,4'-trimethylangelicin (TM A) and khellin recently proposed for the same thera peutical use. TMP and TMA exhibit a significant inhibitory effect on cyclic AMP phosphodiesterase; a light inhibition is produced by khellin at rather high concentration.
Introduction
T h e influence of dihydropyrano-and dihydrofu ran o co u m arin s on the cyclic 3 ',5 '-A M P (cA M P) level in guinea-pig m yocardial tissue and on the activity of purified beef heart cA M P p h o sp h o d iester ase (cA M P -P D E ) [EC 3.1.4.17] is described in the lite ra tu re [1 ] ; results on the topic show th a t the coro n ary v asodilatatory activity is co rrelated both w ith th e increase of cA M P level and the inhibition of cA M P -P D E .
In this study we rep o rt the results on the behaviour o f cA M P -P D E from rat liver in the presence of p so rale n , 8 -m ethoxypsoralen (8 -M O P ), 4 ,5 ',8 -tri m eth y lp soralen (TM P) (furocoum arins usually em p lo y ed in the P U V A therap y of som e skin diseases), angelicin (reference com pound of angular fu ro co u m arin s), 4,6,4'-trim ethylangelicin (T M A ) and k h ellin , a natural furanochrom one contained in A m n i visnaga plant. T he two last com pounds are p h o to th e ra p e u tic agents under clinical investigation [ 2 -7 ] . A s re p o rte d in th e T ab le, p so ralen , angelicin, 8 -M O P and khellin d o e s n 't significantly affect cA M P -P D E at a co n cen tratio n of 1 x 10~4 m ; at the sam e co n cen tratio n T M A and T M P exhibit an a p p ro x im ate inhibition of 4 0 -45% statistically signifi can t fo r p < 0.01. P relim inary results indicate th at at low er co n cen tratio n (1 x 10-5 m ) only T M A and T M P exhibit a light inhibition value of ab o u t 20% . T h e cA M P -P D E has an app ro x im ate inhibition of 15% in th e p resen ce o f 1 x 10-3 m khellin (proposed fo r topical use at ra th e r high co n cen tratio n ) [6 ] . T he ex p o su re o f th e assay m ixtures to th e U V -A light of 365 nm (1 J/cm 2) d o e sn 't significantly affect the results o b tain ed .
T he study is w o rth com pletion. F u tu re researches how ever should be m ade considering th a t cA M P-P D E is d escrib ed as a group of isoenzym es th at exhibits m ultiple form s w ith different substrate specificities an d k inetic p ro p erties: th e re fo re, we con sid er it useful, especially in respect to th e therapy o f psoriasis, to study th e beh av io u r of th e fu ro coum arins (o r drug structurally related ) tow ards ep id erm al cA M P -P D E . Infact literatu re d ata [8 ] re p o rt th a t in th e com plex pathophysiology o f psoriasis a defective cA M P cascade ap p ears to be a very im p o rta n t facto r: th e m ost likely sites for this m etabolic defect are at cell surface, adenylate cyclase com plex o r at level of d eg rad atio n o f cA M P by P D E . O bvi ously a p h o to th e ra p e u tic agent exhibiting an e n h an ced in h ib ito ry effect on th e skin cA M P -P D E w ould be a m o re effective drug th an a com pound dep riv ed of this p ro p erty . Materials cA M P Kit was from A m ersham R adiochem ical C e n te r (A m ersham , E ngland), cA M P was from B o ehringer (B oehringer M annheim , G erm an y ), psoralen and angelicin from F ranco Indian C om pany (B om bay, India), 8 -M O P from C hinoin SpA (M ilano, Italy), T M P from Sigma C hem ical C o m pany (St. L ouis, M O , U S A ), khellin from F luka (B uchs, Sw itzerland); T M A was p re p a re d according to reference [3] .
Results

Preparation o f liver hom ogenate
W istar rats w eighing approxim ately 180 g, fed on a norm al m ixed laborato ry diet, w ere used in this study. T he rats w ere killed by cervical dislocation and the liver was im m ediately hom ogenized in 1:5 ratio (w/v) in 50 mM Tris-H C l buffer pH 7.6. T he hom ogenate was centrifuged at 2 0 ,0 0 0 x g x 2 0 min a t 4 °C in a A L C 972R centrifuge. T he precip itate was discarded and the su p e rn a tan t resu sp en d ed to the original volum e w ith the sam e buffer used fo r th e hom ogenization. T he fraction was p re p a re d just before use.
Experimental
Chem ical solutions w ere p rep ared at co n cen tra tio n 3.3 x 10-4 m containing 1% ethanol.
A ssa y o f c A M P -P D E activity
T he enzym atic activity was assayed in an incuba tion m ixture of 0.2 ml containing 50 mM Tris-H C l p H 7.6, 10 m M M gC l2, 1 m M cA M P and khellin or p so ralen s tested at final concentration of 1 x 1 0 -4 m. T h e reactio n was started by adding a su p ern atan t eq u iv alen t to 4 mg of fresh tissue. Successive o p e ra tions w ere carried o u t using the kit A m ersham as d escribed by Lusini and Ricci [9] . T he ethanol co n ce n tratio n presen t in the assay m ixture do esn 't affect enzym atic activity. P roteins w ere determ in ed by L ow ry m eth o d as rep o rted in [9] . E nzym atic unit is expressed as nm ol of cA M P hydrolyzed/m in/m g p ro tein. W hen req u ired , the assay m ixtures w ere ex p o sed to U V -A rad iatio n using a lam p H PW 125 W Philips; th e irradiance of the em itted light was m eas u red w ith an O S R A M U V -M eter. T he radioactivity was m easu red w ith a Searle N uclear Chicago D elta 300 L iquid Scintillation C ounter.
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